In 2024, the U.S. Drug Enforcement Administration (DEA) indicated which they plan to reclassify cannabis for a Schedule III drug. This rescheduling will acknowledge that cannabis has legitimate health care needs and can help open up the doorway to investigation on other opportunity cure makes us